In the current study, eight ARMS patients had the PAX-FOXO1 fusion gene, accompanied by multiple metastases, most of these patients had a dismal prognosis, with recurrence occurring during treatment. This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.